|
|
Build Your Online Product Catalogs?
| Product Name: |
Carmustine(154-93-8)
|
| Supply Ability: |
500kg |
| Related proudcts |
|
| Specifications |
1kg/bag, 25kg/drum |
| Price Term: |
FOB,CIF, CNF,EXW |
| Port of loading: |
Shanghai, Tianjin,Qingdao, Ningbo |
| Minimum Order |
50g |
| Unit Price: |
Negotiated |
|
XI'AN VEDA CHEMICAL markets APIs (active pharmaceutical ingredients) and We also supply intermediates for the production of APIs.
Our APIs are manufactured by certified ingredients and are known for accurate composition, safe usage, non-toxicity and correct pH value.
We supply chemicals in both bulk industry scale and R&D laboratory scale. Also we are always ready to take on custom synthesis projects.
We pride ourselves of our quality personal service.
Formula:C5H9Cl2N3O2
Molecular weight:214.0511
EINECS:205-838-2
CAS RN:154-93-8
CAS Name:
Synonyms:1,3-bis(2-chloroethyl)-1-nitrosourea; Nitrumon; Carmubris; Gliadel£»1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA£»1,3-BIS(2-CHLOROETHYL)NITROSOUREA£»BCNU£»BECENUN£»BICNU£»bis(2-chloroethyl)nitrosourea£»CARMUSTIN£»CARMUSTINE£»N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA£»NSC-409962£»1,3-bis(2-chloroethyl)-1-nitroso-ure£»1,3-bis(beta-chloroethyl)-1-nitrosourea£»bischlorethylnitrosurea£»bischloroethylnitrosourea£»carmubris£»fda0345
n,n¡¯-bis(2-chloroethyl)-n-nitroso-ure£»nci-c04773£»nitrumon£»sk27702
Minimum assay:min. 98.0 area%
Minimum stability:
Appearance:Light Yellow Powder
Form:Light Yellow Powder
Solubility:Soluble in water (4 mg/ml), and 50% ethanol (150 mg/ml).
Application:It is used in the treatment of brain tumors and various other malignant neoplasms.
Melting point ca.:30 ℃ (lit.)
Boiling point ca.:33.07 ℃ (Predicted)
Density g/cm3 (20℃):1.50 g/cm3
Refractive index: 1.55
Flash point:
Stability:
Percent Composition:
Packaging:
Storage:Store at -20¡ã C
|
| Company: |
Xi'an Veda Chemical Co.,Ltd
|
| Contact: |
Ms. Echo Li |
| Address: |
No.4 Hanguang South Road,Yanta District,Xi'an,710000,China |
| Postcode: |
710065 |
| Tel: |
86-29-88665278 |
| Fax: |
86-29-88665278 |
| E-mail: |
|
|
|
|
Home
